Even though significant differences exist between CSA-AKI and other types of AKI in etiology, pathophysiology, symptoms and treatment, there is currently no available predictive biomarkers or diagnostic criteria specific for CSA-AKI beyond the general clinical variables for AKI, such as SCr and cystatin C. This evidence concerns the gene CST3 and chromosome-type aberration frequency.